Selected research
Industry Research
Seasickness Medicine Industry Research Report 2026
Market perspective
The global Seasickness Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Seasickness Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Seasickness Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Seasickness Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Seasickness Medicine include Baxter International, Caleb Pharmaceuticals, Myungmoon Pharm, Prestige Brands, WellSpring Pharmaceutical Corporation, GlaxoSmithKline, Pfizer, Mylan and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Seasickness Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Seasickness Medicine Market by Company
Baxter International
Caleb Pharmaceuticals
Myungmoon Pharm
Prestige Brands
WellSpring Pharmaceutical Corporation
GlaxoSmithKline
Pfizer
Mylan
Novartis
Seasickness Medicine Segment by Type
Anticholinergic
Antihistamines
Others
Seasickness Medicine Segment by Application
Adults
Children
Seasickness Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasickness Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasickness Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasickness Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Seasickness Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Seasickness Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Seasickness Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anticholinergic
- Antihistamines
- Others
Applications
- Adults
- Children
Companies covered
- Baxter International
- Caleb Pharmaceuticals
- Myungmoon Pharm
- Prestige Brands
- WellSpring Pharmaceutical Corporation
- GlaxoSmithKline
- Pfizer
- Mylan
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Seasickness Medicine Market Size (2021-2032)
- 2.2.2 Global Seasickness Medicine Sales (2021-2032)
- 2.2.3 Global Seasickness Medicine Market Average Price (2021-2032)
- 2.3 Seasickness Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anticholinergic
- 2.3.3 Antihistamines
- 2.3.4 Others
- 2.4 Seasickness Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Seasickness Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Seasickness Medicine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Seasickness Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Seasickness Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Seasickness Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Seasickness Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Seasickness Medicine, Product Type & Application
- 3.8 Global Manufacturers of Seasickness Medicine, Established Date
- 3.9 Global Seasickness Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Baxter International
- 4.1.1 Baxter International Company Information
- 4.1.2 Baxter International Business Overview
- 4.1.3 Baxter International Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Baxter International Seasickness Medicine Product Portfolio
- 4.1.5 Baxter International Recent Developments
- 4.2 Caleb Pharmaceuticals
- 4.2.1 Caleb Pharmaceuticals Company Information
- 4.2.2 Caleb Pharmaceuticals Business Overview
- 4.2.3 Caleb Pharmaceuticals Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Caleb Pharmaceuticals Seasickness Medicine Product Portfolio
- 4.2.5 Caleb Pharmaceuticals Recent Developments
- 4.3 Myungmoon Pharm
- 4.3.1 Myungmoon Pharm Company Information
- 4.3.2 Myungmoon Pharm Business Overview
- 4.3.3 Myungmoon Pharm Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Myungmoon Pharm Seasickness Medicine Product Portfolio
- 4.3.5 Myungmoon Pharm Recent Developments
- 4.4 Prestige Brands
- 4.4.1 Prestige Brands Company Information
- 4.4.2 Prestige Brands Business Overview
- 4.4.3 Prestige Brands Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Prestige Brands Seasickness Medicine Product Portfolio
- 4.4.5 Prestige Brands Recent Developments
- 4.5 WellSpring Pharmaceutical Corporation
- 4.5.1 WellSpring Pharmaceutical Corporation Company Information
- 4.5.2 WellSpring Pharmaceutical Corporation Business Overview
- 4.5.3 WellSpring Pharmaceutical Corporation Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 WellSpring Pharmaceutical Corporation Seasickness Medicine Product Portfolio
- 4.5.5 WellSpring Pharmaceutical Corporation Recent Developments
- 4.6 GlaxoSmithKline
- 4.6.1 GlaxoSmithKline Company Information
- 4.6.2 GlaxoSmithKline Business Overview
- 4.6.3 GlaxoSmithKline Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GlaxoSmithKline Seasickness Medicine Product Portfolio
- 4.6.5 GlaxoSmithKline Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Seasickness Medicine Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Seasickness Medicine Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Novartis
- 4.9.1 Novartis Company Information
- 4.9.2 Novartis Business Overview
- 4.9.3 Novartis Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novartis Seasickness Medicine Product Portfolio
- 4.9.5 Novartis Recent Developments
5 Global Seasickness Medicine Market Scenario by Region
- 5.1 Global Seasickness Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Seasickness Medicine Sales by Region: 2021-2032
- 5.2.1 Global Seasickness Medicine Sales by Region: 2021-2026
- 5.2.2 Global Seasickness Medicine Sales by Region: 2027-2032
- 5.3 Global Seasickness Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Seasickness Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Seasickness Medicine Revenue by Region: 2027-2032
- 5.4 North America Seasickness Medicine Market Facts & Figures by Country
- 5.4.1 North America Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Seasickness Medicine Sales by Country (2021-2032)
- 5.4.3 North America Seasickness Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Seasickness Medicine Market Facts & Figures by Country
- 5.5.1 Europe Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Seasickness Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Seasickness Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Seasickness Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Seasickness Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Seasickness Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Seasickness Medicine Market Facts & Figures by Country
- 5.7.1 South America Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Seasickness Medicine Sales by Country (2021-2032)
- 5.7.3 South America Seasickness Medicine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Seasickness Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Seasickness Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Seasickness Medicine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Seasickness Medicine Sales by Type (2021-2032)
- 6.1.1 Global Seasickness Medicine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Seasickness Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Seasickness Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Seasickness Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Seasickness Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Seasickness Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Seasickness Medicine Sales by Application (2021-2032)
- 7.1.1 Global Seasickness Medicine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Seasickness Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Seasickness Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Seasickness Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Seasickness Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Seasickness Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Seasickness Medicine Value Chain Analysis
- 8.1.1 Seasickness Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Seasickness Medicine Production Mode & Process
- 8.2 Seasickness Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Seasickness Medicine Distributors
- 8.2.3 Seasickness Medicine Customers
9 Global Seasickness Medicine Analyzing Market Dynamics
- 9.1 Seasickness Medicine Industry Trends
- 9.2 Seasickness Medicine Industry Drivers
- 9.3 Seasickness Medicine Industry Opportunities and Challenges
- 9.4 Seasickness Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst